Close

Share this page

China

EPSI has operated in China since 2006 and we have set up offices across the region. With approximately 10 years of combined clinical research experience, EPSI believes that it can provide possible solutions to bring your project to success.


Fast Facts

Health Expenditure per Capita
(2018, US$)

$436

Source: Financing Global Health Database 2018

Population(2019)
 

1398

million people

Source: The World Bank

Burden of Disease DALYs Causes % of Total DALYs
(2017, all ages/both sexes)

Stroke (11.95%)

Ischemic heart disease (8.13%)

Chronic obstractive pulmonary
disease (5.51%)

Source: Institute Health Matrics and Evaluation GBD

NDA Approval Time

12

months



14

months

Study Start-up Time

11

months



13

months




Features

Clinical Trials in China: the potential and pitfalls

Clinical trials are a global industry, but many companies are reconsidering where they will conduct their work in the future. One of the most promising locations is China. The potential for clinical trials in China is great ...

Post-marketing surveillance in China: what it reveals

With a population of over 1.3 billion people and an annual increase of approximately 16 million people, China requires 500 million vaccine doses each year. Recent additions to the national immunization schedule combined ...


Services Available in China

We will tailor an ideal solution for your specific needs.

Contact Us